Keegan Theresa H M, DeRouen Mindy C, Parsons Helen M, Clarke Christina A, Goldberg Debbie, Flowers Christopher R, Glaser Sally L
Division of Hematology and Oncology, Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, California.
Cancer Prevention Institute of California, Fremont, California.
Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):264-73. doi: 10.1158/1055-9965.EPI-15-0756. Epub 2016 Jan 29.
Previous studies documented racial/ethnic and socioeconomic disparities in survival after Hodgkin lymphoma among adolescents and young adults (AYA), but did not consider the influence of combined-modality treatment and health insurance.
Data for 9,353 AYA patients ages 15 to 39 years when diagnosed with Hodgkin lymphoma during 1988 to 2011 were obtained from the California Cancer Registry. Using multivariate Cox proportional hazards regression, we examined the impact of sociodemographic characteristics [race/ethnicity, neighborhood socioeconomic status (SES), and health insurance], initial combined-modality treatment, and subsequent cancers on survival.
Over the 24-year study period, we observed improvements in Hodgkin lymphoma-specific survival by diagnostic period and differences in survival by race/ethnicity, neighborhood SES, and health insurance for a subset of more recently diagnosed patients (2001-2011). In multivariable analyses, Hodgkin lymphoma-specific survival was worse for Blacks than Whites with early-stage [HR: 1.68; 95% confidence interval (CI): 1.14-2.49] and late-stage disease (HR: 1.68; 95% CI, 1.17-2.41) and for Hispanics than Whites with late-stage disease (HR: 1.58; 95% CI, 1.22-2.04). AYAs diagnosed with early-stage disease experienced worse survival if they also resided in lower SES neighborhoods (HR: 2.06; 95% CI, 1.59-2.68). Furthermore, more recently diagnosed AYAs with public health insurance or who were uninsured experienced worse Hodgkin lymphoma-specific survival (HR: 2.08; 95% CI, 1.52-2.84).
Our findings identify several subgroups of Hodgkin lymphoma patients at higher risk for Hodgkin lymphoma mortality.
Identifying and reducing barriers to recommended treatment and surveillance in these AYAs at much higher risk of mortality is essential to ameliorating these survival disparities.
既往研究记录了青少年和青年(AYA)霍奇金淋巴瘤患者生存方面的种族/族裔及社会经济差异,但未考虑综合治疗方式和健康保险的影响。
从加利福尼亚癌症登记处获取了1988年至2011年期间确诊为霍奇金淋巴瘤时年龄在15至39岁的9353例AYA患者的数据。使用多变量Cox比例风险回归,我们研究了社会人口学特征[种族/族裔、社区社会经济地位(SES)和健康保险]、初始综合治疗方式以及后续癌症对生存的影响。
在24年的研究期间,我们观察到霍奇金淋巴瘤特异性生存率按诊断时期有所改善,并且对于一部分最近确诊的患者(2001 - 2011年),其生存情况在种族/族裔、社区SES和健康保险方面存在差异。在多变量分析中,黑人早期[风险比(HR):1.68;95%置信区间(CI):1.14 - 2.49]和晚期疾病患者的霍奇金淋巴瘤特异性生存率低于白人[HR:1.68;95% CI,1.17 - 2.41],西班牙裔晚期疾病患者低于白人(HR:1.58;95% CI,1.22 - 2.04)。确诊为早期疾病的AYA患者若居住在SES较低的社区,其生存情况更差(HR:2.06;95% CI,1.59 - 2.68)。此外,最近确诊的有公共健康保险或未参保的AYA患者的霍奇金淋巴瘤特异性生存率更差(HR:2.08;95% CI,1.52 - 2.84)。
我们的研究结果确定了几个霍奇金淋巴瘤患者亚组,这些亚组的霍奇金淋巴瘤死亡风险更高。
识别并减少这些死亡风险高得多的AYA患者在接受推荐治疗和监测方面的障碍,对于改善这些生存差异至关重要。